Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Investigational

144

Possibly Marketed Outside US

78

US Previously Marketed

65

US Approved Rx

58

US Approved OTC

34

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Histamine H1 receptor

125

Hepatitis C virus

7

Histamine H2 receptor

7

Cytochrome P450 2D6

6

Cytochrome P450 3A4

6

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

168

Phase III

15

Phase II

11

Not Provided

5

Phase I

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

213

1948

14

1949

10

1960

10

1959

8

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Allergic rhinitis

33

Allergy

25

Allergic conjunctivitis

19

Seasonal allergic rhinitis

17

Urticaria

12

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

148

Palliative

60

Preventing

22

Curative

9

Diagnostic

4

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Active

76

CNS Penetrant

36

CNS Non-penetrant

25

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

UCB

7

Ciba-Geigy

6

Kaken Pharmaceutical

6

Boehringer Ingelheim

5

Janssen Pharmaceutica

5

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

339

Protein

29

Structurally Diverse

9

Polymer

4

Concept

3

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

NCI_THESAURUS

387

FDA UNII

385

CAS

380

PUBCHEM

340

ChEMBL

310

All Match

Any Match

Exclude Selected

Exclude Selected

Protein Type

MONOCLONAL ANTIBODY

12

CYTOKINE

1

FUSION PROTEIN

1

MONOCLONAL ANTIBODY CONJUGATE

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

RESPIRATORY SYSTEM

46

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

33

DERMATOLOGICALS

12

SENSORY ORGANS

12

NERVOUS SYSTEM

5

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANTIHISTAMINES FOR SYSTEMIC USE

38

IMMUNOSUPPRESSANTS

23

OPHTHALMOLOGICALS

12

ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.

8

NASAL PREPARATIONS

8

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

ANTIHISTAMINES FOR SYSTEMIC USE

38

IMMUNOSUPPRESSANTS

23

DECONGESTANTS AND ANTIALLERGICS

9

ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.

8

DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE

8

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Other antihistamines for systemic use

17

Antihistamines for topical use

8

Other antiallergics

8

Selective immunosuppressants

8

Other immunostimulants

7

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

246

Salts, Hydrates, Esters, etc.

139

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Pharmacologic Substance[C1909]|Immunotherapeutic Agent[C308]" in comments (approximate match)

Showing 381 - 387 of 387 results

First page
Previous page
39
Next page disabled
Next page disabled

ETYMEMAZINE HYDROCHLORIDE

A7002E7T2Z

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

LATREPIRDINE DIHYDROCHLORIDE

8B9414QQ5M

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

TRAMAZOLINE HYDROCHLORIDE

4DG710Q678

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

THIAZINAMIUM CHLORIDE

89SV0QH69Q

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

AGATOLIMOD SODIUM

I4Z5C8FM6H

Export Data
Sequence Search

Status:

Other

Class:

NUCLEIC ACID

ECHINACEA EXTRACT

4N9P6CC1DX

Status:

Other

Class:

CONCEPT

CHLORPHENIRAMINE POLISTIREX

3U6IO1965U

Status:

Other

Class:

CONCEPT

Showing 381 - 387 of 387 results

First page
Previous page
39
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1